Drugs / VIB9600
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03621605 | Aug 2018 → Apr 2019 | — | Amgen | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VIB9600 | “Single dose of VIB9600 administered by IV infusion or SC injection.” NCT03621605 ↗ |
| Route | Intravenous | “Single dose of VIB9600 administered by IV infusion or SC injection.” NCT03621605 ↗ |
| Route | Subcutaneous | “Single dose of VIB9600 administered by IV infusion or SC injection.” NCT03621605 ↗ |